Funding round-up: Brain+, Teitur Trophics, AlgoTx, Iktos

France: Iktos, a company specializing in artificial intelligence for new drug discovery, has closed a €15.5m (US$16.4m) Series A financing co-led by new investors M Ventures and Debiopharm Innovation Fund with participation from Omnes Capital. Financing will enable the company to further develop its AI and drug discovery capabilities and expand its existing SaaS software offering, in…

You must be a HMI Subscriber to view this content.

Subscribe Now »